No increased mortality in patients with rheumatoid arthritis: up to 10 years of follow up from disease onset. 2000

E J Kroot, and M A van Leeuwen, and M H van Rijswijk, and M L Prevoo, and M A Van 't Hof, and L B van De Putte, and P L van Riel
Department of Rheumatology, University Medical Centre Nijmegen, Nijmegen, The Netherlands. E.Kroot@reuma.azn.nl

OBJECTIVE To investigate mortality, functional capacity, and prognostic factors for mortality in an inception cohort of patients with recently diagnosed RA followed up for up to 10 years. METHODS The observed mortality of this inception cohort with recently diagnosed RA, was analysed in relation to the expected mortality, calculated with the aid of life tables of the general population of the Netherlands (matched for age and sex). Functional capacity was measured by the Health Assessment Questionnaire. Prognostic factors for mortality were analysed multivariately by the Cox proportional hazards model. RESULTS Between January 1985 and April 1997, 622 patients entered the study, and were included in the analysis of mortality. The death rate in the first 10 years of the disease was not significantly different from that of the general population. Fifty five patients from the study group died (16% up to 10 years of follow up). The most commonly reported causes of death were of cardiovascular and respiratory origin. The other causes of death could be classified into cancer, sepsis, amyloidosis, leukaemia, renal insufficiency of unknown cause, perforation of the oesophagus, probably related to the treatment with non-steroidal anti-inflammatory drugs, and pancytopenia during aurothioglucose treatment. Functional capacity improved significantly during the first six years compared with the value at start. Statistically significant predictors for death were age at the start and male sex. CONCLUSIONS In contrast with earlier studies performed, no excess mortality in the first 10 years of an inception cohort of patients with RA was seen. In addition, the functional capacity was relatively constant during the first six years after an initial improvement from baseline. Age at start and male sex were the only statistically significant predictors for death.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009426 Netherlands Country located in EUROPE. It is bordered by the NORTH SEA, BELGIUM, and GERMANY. Constituent areas are Aruba, Curacao, and Sint Maarten, formerly included in the NETHERLANDS ANTILLES. Holland,Kingdom of the Netherlands
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D011446 Prospective Studies Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group. Prospective Study,Studies, Prospective,Study, Prospective
D002423 Cause of Death Factors which produce cessation of all vital bodily functions. They can be analyzed from an epidemiologic viewpoint. Causes of Death,Death Cause,Death Causes
D005260 Female Females
D006304 Health Status The level of health of the individual, group, or population as subjectively assessed by the individual or by more objective measures. General Health,General Health Level,General Health Status,Level of Health,Overall Health,Overall Health Status,General Health Levels,Health Level,Health Level, General,Health Levels,Health Status, General,Health Status, Overall,Health, General,Health, Overall,Level, General Health,Levels, General Health,Status, General Health,Status, Health,Status, Overall Health
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths

Related Publications

E J Kroot, and M A van Leeuwen, and M H van Rijswijk, and M L Prevoo, and M A Van 't Hof, and L B van De Putte, and P L van Riel
August 2022, Annals of the rheumatic diseases,
E J Kroot, and M A van Leeuwen, and M H van Rijswijk, and M L Prevoo, and M A Van 't Hof, and L B van De Putte, and P L van Riel
November 2010, Annals of the rheumatic diseases,
E J Kroot, and M A van Leeuwen, and M H van Rijswijk, and M L Prevoo, and M A Van 't Hof, and L B van De Putte, and P L van Riel
January 2019, Clinical and experimental rheumatology,
E J Kroot, and M A van Leeuwen, and M H van Rijswijk, and M L Prevoo, and M A Van 't Hof, and L B van De Putte, and P L van Riel
January 1999, Annals of the rheumatic diseases,
E J Kroot, and M A van Leeuwen, and M H van Rijswijk, and M L Prevoo, and M A Van 't Hof, and L B van De Putte, and P L van Riel
October 2009, Arthritis and rheumatism,
E J Kroot, and M A van Leeuwen, and M H van Rijswijk, and M L Prevoo, and M A Van 't Hof, and L B van De Putte, and P L van Riel
March 1996, Annals of the rheumatic diseases,
E J Kroot, and M A van Leeuwen, and M H van Rijswijk, and M L Prevoo, and M A Van 't Hof, and L B van De Putte, and P L van Riel
January 2018, PloS one,
E J Kroot, and M A van Leeuwen, and M H van Rijswijk, and M L Prevoo, and M A Van 't Hof, and L B van De Putte, and P L van Riel
January 1978, Archivum immunologiae et therapiae experimentalis,
E J Kroot, and M A van Leeuwen, and M H van Rijswijk, and M L Prevoo, and M A Van 't Hof, and L B van De Putte, and P L van Riel
April 2017, Seminars in arthritis and rheumatism,
E J Kroot, and M A van Leeuwen, and M H van Rijswijk, and M L Prevoo, and M A Van 't Hof, and L B van De Putte, and P L van Riel
July 2005, Archives of dermatology,
Copied contents to your clipboard!